Condition: Suicide, Attempted · Suicidal Ideation · Depression · Sponsor: Weill Medical College of Cornell University
The goal of this project is to test whether WellPATH-PREVENT (a novel, mobile psychosocial intervention) improves a specific aspect of emotion regulation, i.e., cognitive reappraisal ability, and reduces suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).
This description comes directly from the study's public registry record.
Dimitris Kiosses, PhD · 914-997-4381 · dkiosses@med.cornell.edu
Laurie Evans, MS · 914-682-9100 · lad9011@med.cornell.edu
Always discuss trial participation with your own doctor first.
| New York Presbyterian Hospital/Weill Cornell Medicine | New York, New York, United States | Not Yet Recruiting |
| Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine | White Plains, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05183230